Maze Therapeutics, Inc.

Direct answer

Maze Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MAZE.

Maze Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the creation of precise small molecule medications for a range of ailments within the United States. Its primary therapeutic targets encompass renal, cardiovascular, and associated metabolic conditions, alongside obesity. The company's developmental pipeline highlights two leading drug candidates: MZE829, an oral small...

Can you invest in Maze Therapeutics, Inc.?

Yes. Maze Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MAZE.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Maze Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.